Clinical research of adenosine triphosphate and spermatic vein ligation combined treatment of children with primary varicocele disease
10.3969/j.issn.1005-1678.2017.05.022
- VernacularTitle:三磷酸腺苷与精索静脉结扎术联合治疗小儿原发性精索静脉曲张疾病的临床研究
- Author:
Zonggang JIANG
;
Yinghao ZHANG
;
Dehua WU
- Keywords:
adenosine triphosphate;
spermatic vein ligation;
combined treatment;
children with primary varicocele disease
- From:
Chinese Journal of Biochemical Pharmaceutics
2017;37(5):71-73
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the clinical effect of adenosine triphosphate and spermatic vein ligation combined treatment of children with primary varicocele disease.Methods80 cases of children with primary varicocele disease who were treated in pediatric surgery department of Hangzhou City Yuhang District MCH from May 2014 to May 2016 were selected, these children were divided into adenosine triphosphate and spermatic vein ligation combined treatment group (combined treatment group, n= 40) and spermatic vein ligation treatment group (monotherapy group, n=40) two groups according to the random number table, the postoperative pain score, gastrointestinal recovery time, hospital stay, cost of hospitalization, incidence of complications and recurrence of the two groups were statistically analyzed.ResultsThe postoperative pain score and hospitalization cost of the combined treatment group were significantly lower (P<0.05), the gastrointestinal function recovery time and hospital stay were significantly shorter (P<0.05), the incidence of complications 2.5% (1/40) was significantly lower than the monotherapy group 17.5% (7/40) (P<0.05), the recurrence rate 2.5% (1/40) was significantly lower than the monotherapy group 10.0% (4/40) (P< 0.05).ConclusionThe clinical effect of adenosine triphosphate and spermatic vein ligation combined treatment of children with primary varicocele disease is better than spermatic vein ligation treatment alone, so is worthy of promotion in the clinical.
